Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
132.7 USD | +0.33% |
|
-2.57% | +16.05% |
Jul. 02 | Goldman Sachs Adjusts Price Target on Xylem to $157 From $159, Maintains Buy Rating | MT |
Jul. 01 | Xylem Inc.(NYSE:XYL) dropped from Russell Midcap Growth Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.05% | 32.07B | |
+13.94% | 86.66B | |
+11.29% | 65.56B | |
+17.73% | 36.58B | |
+7.93% | 26.15B | |
-1.83% | 25.45B | |
-2.02% | 25.14B | |
+15.06% | 24.32B | |
-2.36% | 20.87B | |
+16.81% | 18.22B |
- Stock Market
- Equities
- XYL Stock
- News Xylem Inc.
- Xylem Q1 Adjusted Earnings, Revenue Rise; 2024 Outlook Lifted